Valuation: Median Technologies

Market Cap 157M 179M 145M 133M 251M 17.29B 257M 1.73B 680M 8.47B 674M 659M 29.14B P/E 2026 *
-9.34x
P/E 2027 * -10.9x
Enterprise Value 174M 199M 160M 148M 279M 19.16B 285M 1.92B 754M 9.38B 747M 731M 32.3B EV / Sales 2026 *
6.84x
EV / Sales 2027 * 5.48x
Free-Float
40.54%
Yield 2026 *
-
Yield 2027 * -
1 week-6.53%
Current month-10.88%
1 month-17.25%
3 months-13.08%
6 months+0.72%
Current year-12.45%
1 week 3.98
Extreme 3.985
4.74
1 month 3.98
Extreme 3.985
5.46
3 years 1.17
Extreme 1.166
7.3
5 years 1.17
Extreme 1.166
17.46
Manager TitleAgeSince
Chief Executive Officer 64 2001-12-31
Director of Finance/CFO - 2021-07-11
Investor Relations Contact - 2019-03-31
Director TitleAgeSince
Chairman 64 2001-12-31
Chairman 64 2019-04-09
Director/Board Member 66 2017-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.61%-6.53%+102.88%-19.47% 186M
-1.74%+1.14%+25.43%+1.49% 202B
-0.34%+2.66%+4.91%-14.05% 145B
-13.75%-14.09%-32.30%-1.24% 142B
-1.57%-1.87%-58.02%-16.49% 66.32B
-2.17%-6.58%+13.07%-7.03% 50.58B
-0.11%+1.53%-24.62%-31.81% 44.81B
-3.07%-2.37%+12.68%+10.88% 38.44B
-2.27%-1.96%+24.30%+36.78% 37.13B
-4.15%-2.60%-17.34%-22.38% 29.89B
Average -3.21%-0.82%+5.10%-6.33% 84.07B
Weighted average by Cap. -3.82%-0.23%-2.85%-4.86%

Financials

2026 *2027 *
Net sales 25.43M 29.1M 23.47M 21.63M 40.77M 2.8B 41.68M 281M 110M 1.37B 109M 107M 4.73B 33.43M 38.26M 30.85M 28.44M 53.6M 3.68B 54.79M 369M 145M 1.8B 144M 141M 6.21B
Net income -15.23M -17.43M -14.06M -12.96M -24.42M -1.68B -24.96M -168M -66.08M -822M -65.46M -64.03M -2.83B -11.23M -12.85M -10.37M -9.55M -18.01M -1.24B -18.41M -124M -48.73M -606M -48.27M -47.21M -2.09B
Net Debt 17M 19.45M 15.69M 14.46M 27.25M 1.87B 27.86M 188M 73.75M 917M 73.06M 71.45M 3.16B 26.5M 30.32M 24.45M 22.54M 42.48M 2.92B 43.43M 292M 115M 1.43B 114M 111M 4.92B
Logo Median Technologies
A pioneer in innovative imaging services and device software, Median Technologies (Median) leverages cutting-edge Artificial Intelligence (AI) technologies to increase the accuracy of early diagnosis and treatment of many cancers. Median's offerings, iCRO for the analysis and management of medical images in oncology clinical trials and eyonis® LCS, a suite of medical device software based on AI technologies, enable biopharmaceutical companies and clinicians to advance patient care and accelerate the development of new therapies. Median is also present in the United States and China.
Employees
-
Date Price Change
26-07-17 3.995 -5.33%
26-07-16 €4.220 -0.35%
26-07-15 €4.235 -3.42%
26-07-14 €4.385 -1.57%
26-07-13 €4.455 -2.73%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.270EUR
Average target price
11.97EUR
Spread / Average Target
+180.25%

Annual profits - Rate of surprise